日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

OPT-In; Optimized Patient Treatment Outcomes in Plaque Psoriasis: A 3-Year State-Transition Treatment-Sequencing Model in the Italian Setting

OPT-In;斑块状银屑病患者治疗结果优化:意大利环境下为期3年的状态转换治疗顺序模型

Alulis, Sarah; Bernardini, Nicoletta; Burlando, Martina; Costanzo, Antonio; Francesa Morel, Pier Cesare; Gisondi, Paolo; Loconsole, Francesco; Megna, Matteo; Pellacani, Giovanni; Piaserico, Stefano; Prignano, Francesca; Secchi, Ottavio; Skroza, Nevena; Hassan, Fareen

Modelling Treatment Sequences in Immunology: Optimizing Patient Outcomes

免疫学治疗序列建模:优化患者疗效

Hart, Rose J; Hassan, Fareen; Alulis, Sarah; Patterson, Karl W; Barthelmes, Jennifer Norma; Boer, Jennifer H; Lee, Dawn

The cost burden of Crohn's disease and ulcerative colitis depending on biologic treatment status - a Danish register-based study

克罗恩病和溃疡性结肠炎的治疗成本负担取决于生物制剂治疗状况——一项基于丹麦登记数据的研究

Alulis, Sarah; Vadstrup, Kasper; Olsen, Jens; Jørgensen, Tine Rikke; Qvist, Niels; Munkholm, Pia; Borsi, Andras

Extraintestinal Manifestations and Other Comorbidities in Ulcerative Colitis and Crohn Disease: A Danish Nationwide Registry Study 2003-2016

溃疡性结肠炎和克罗恩病肠外表现及其他合并症:一项丹麦全国注册研究(2003-2016)

Vadstrup, Kasper; Alulis, Sarah; Borsi, Andras; Jørgensen, Tine Rikke; Nielsen, Agnete; Munkholm, Pia; Qvist, Niels

The SP1 sites of the human apoCIII enhancer are essential for the expression of the apoCIII gene and contribute to the hepatic and intestinal expression of the apoA-I gene in transgenic mice

人载脂蛋白CIII增强子的SP1位点对于载脂蛋白CIII基因的表达至关重要,并促进转基因小鼠肝脏和肠道中载脂蛋白A-I基因的表达。

Georgopoulos, S; Kan, H Y; Reardon-Alulis, C; Zannis, V